Wells Fargo’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $294K | Buy |
84,980
+9,466
| +13% | +$32.8K | ﹤0.01% | 4136 |
|
2025
Q1 | $198K | Buy |
75,514
+4,089
| +6% | +$10.7K | ﹤0.01% | 4270 |
|
2024
Q4 | $294K | Sell |
71,425
-59,042
| -45% | -$243K | ﹤0.01% | 4066 |
|
2024
Q3 | $924K | Buy |
130,467
+86,662
| +198% | +$614K | ﹤0.01% | 3251 |
|
2024
Q2 | $286K | Buy |
43,805
+10,274
| +31% | +$67K | ﹤0.01% | 3920 |
|
2024
Q1 | $278K | Buy |
33,531
+5,682
| +20% | +$47.2K | ﹤0.01% | 3906 |
|
2023
Q4 | $307K | Sell |
27,849
-63,741
| -70% | -$702K | ﹤0.01% | 3835 |
|
2023
Q3 | $770K | Sell |
91,590
-49,651
| -35% | -$418K | ﹤0.01% | 3248 |
|
2023
Q2 | $1.77M | Buy |
141,241
+51,516
| +57% | +$647K | ﹤0.01% | 2860 |
|
2023
Q1 | $1.48M | Buy |
89,725
+88,819
| +9,803% | +$1.46M | ﹤0.01% | 2922 |
|
2022
Q4 | $13.5K | Sell |
906
-1,727
| -66% | -$25.8K | ﹤0.01% | 5103 |
|
2022
Q3 | $59K | Sell |
2,633
-748
| -22% | -$16.8K | ﹤0.01% | 4575 |
|
2022
Q2 | $56K | Sell |
3,381
-20,713
| -86% | -$343K | ﹤0.01% | 4702 |
|
2022
Q1 | $721K | Sell |
24,094
-22,726
| -49% | -$680K | ﹤0.01% | 3892 |
|
2021
Q4 | $1.44M | Sell |
46,820
-3,646
| -7% | -$112K | ﹤0.01% | 3570 |
|
2021
Q3 | $1.59M | Buy |
50,466
+19,867
| +65% | +$627K | ﹤0.01% | 3671 |
|
2021
Q2 | $1.12M | Buy |
30,599
+20,779
| +212% | +$761K | ﹤0.01% | 3914 |
|
2021
Q1 | $340K | Sell |
9,820
-13,386
| -58% | -$463K | ﹤0.01% | 4591 |
|
2020
Q4 | $964K | Sell |
23,206
-9,810
| -30% | -$408K | ﹤0.01% | 3993 |
|
2020
Q3 | $1.41M | Buy |
+33,016
| New | +$1.41M | ﹤0.01% | 3538 |
|